Literature DB >> 25814620

Pushing the limits of chemistry point-of-care testing for the management of patients under investigation for Ebola virus disease.

Jason J LeBlanc1, Charles Heinstein2, James MacDonald2, Roy Gallant2, Catherine Roberts2, Colleen Jackson2, Amy Lou3, Bassam A Nassar3, Todd F Hatchette3.   

Abstract

BACKGROUND: With the recent outbreak in West Africa, hospitals worldwide have been developing protocols for suspect of cases of Ebola virus disease. Patients with Ebola virus disease present with a severe gastroenteritis leading to dehydration and electrolyte abnormalities and as such, routine chemistry analysis is essential for patient management. While point-of-care testing can be used with additional precautions for rapid chemistry analyses in a laboratory setting, significant delays could ensue before specimens arrive to the laboratory. This study evaluated the stability of eight chemistry analytes up to 4 h post-collection.
METHODS: Blood was collected by venipuncture from 20 healthy volunteers and tested at times 0, 30, 60, 90, 120 and 240 h. Approximately 100 µl of blood was dispensed into a CHEM 8+Cartridge and processed on a model 300 i-STAT 1 Analyzer (Abbott Point of Care Inc.) and ANOVA was used to assess statistical significant difference from the initial time point.
RESULTS: While the manufacturer recommends testing within 30 min of collection, no significant variation was observed for most analytes with time points extending up to 4 h. In contrast, glucose concentrations decreased significantly (P < 0.0001) over time at an average rate of 0.0032 mmol/L per min.
CONCLUSIONS: This study provides supporting data suggesting that delays up to 4 h can be tolerated, giving ample time for collection and transport of specimens to the clinical laboratory. For glucose, POC testing could still be used, taking into account the collection time and the average rate of decrease.
© The Author(s) 2015.

Entities:  

Keywords:  Electrolytes; point-of-care testing; quality assurance and control

Mesh:

Year:  2015        PMID: 25814620     DOI: 10.1177/0004563215581651

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  1 in total

1.  Ebola Infection and Diabetes Mellitus.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Iran J Pathol       Date:  2016
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.